You have no items in your shopping cart.
On Promotion 
Species Host
Tested Applications
Predicted Reactivity
Conjugation
Featured Product
NVP-BSK805 2HCl (1092499-93-8(free base)) [orb1300895]1 ml x 10 mM (in DMSO), 200 mg, 1 mg, 10 mg, 25 mg, 50 mg, 100 mg, 5 mg- Ifidancitinib [orb1691879]
98.05%
1236667-40-5
395.39
C20H18FN5O3
- JAK2-IN-6 [orb1690587]
99.64%
353512-04-6
335.83
C14H10ClN3OS2
5 mg, 1 mg, 10 mg, 25 mg, 100 mg, 200 mg, 50 mg - JAK1-IN-8 [orb1694218]
98.40%
1973485-18-5
442.51
C22H23FN4O3S
5 mg, 1 ml x 10 mM (in DMSO), 10 mg, 25 mg, 50 mg, 100 mg, 200 mg - Abrocitinib [orb1296253]
99.91%
1622902-68-4
323.41
C14H21N5O2S
5 mg, 50 mg, 100 mg, 2 mg, 1 ml x 10 mM (in DMSO), 10 mg, 25 mg - Brepocitinib [orb1296275]
98.00%
1883299-62-4
389.4
C18H21F2N7O
200 mg, 1 ml x 10 mM (in DMSO), 100 mg, 10 mg, 25 mg, 50 mg, 2 mg, 5 mg, 1 mg - SAR-20347 [orb1303059]
99.77%
1450881-55-6
444.84
C21H18ClFN4O4
5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 mg, 1 ml x 10 mM (in DMSO), 200 mg - Delgocitinib [orb1308395]
99.95%
1263774-59-9
310.35
C16H18N6O
50 mg, 100 mg, 5 mg, 25 mg, 1 ml x 10 mM (in DMSO), 200 mg, 1 mg, 10 mg